Advanced Wound Dressing

Advanced Wound Dressing Market Outlook

The global advanced wound dressing market is projected to reach USD 12.3 billion by 2035, growing at a CAGR of 5.8% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of chronic wounds, including diabetic ulcers and pressure sores, alongside the rising aging population that is more susceptible to wound-related complications. Additionally, advancements in wound care technologies, such as the development of bioactive dressings that facilitate healing, are expected to bolster market expansion. The growing emphasis on better healthcare facilities and improved patient outcomes has also contributed to the demand for advanced wound care products, which offer more efficient healing and infection control compared to traditional dressings. Furthermore, the rise in surgical procedures due to the increasing incidence of traumatic injuries and the demand for post-operative wound management are further fueling market growth.

Growth Factor of the Market

The advanced wound dressing market is witnessing significant growth due to various factors that enhance its demand globally. A key growth factor includes the increasing awareness among healthcare professionals and patients regarding advanced wound care solutions, which has led to a rise in the adoption of advanced dressings over traditional methods. Furthermore, innovations in product offerings that incorporate antimicrobial properties and promote faster healing are also attracting attention. The growing number of surgical interventions, as well as an increase in the prevalence of lifestyle-related conditions such as obesity and diabetes, contribute to higher incidences of chronic wounds, thus driving the need for advanced wound care products. In addition, the development of advanced materials that enhance moisture retention and facilitate gas exchange is significantly improving patient outcomes, further fostering market growth. With an evolving healthcare landscape and improved distribution channels, the accessibility of advanced wound dressings is on the rise.

Key Highlights of the Market

• Expected growth of the market to USD 12.3 billion by 2035 with a CAGR of 5.8%.
• Increasing prevalence of chronic conditions driving demand for advanced dressings.
• Technological advancements leading to the development of bioactive wound dressings.
• Growing surgical interventions and trauma cases necessitating advanced wound care solutions.
• Enhanced product innovations focusing on antimicrobial and moisture-retentive properties.

By Product Type

Foam Dressings:

Foam dressings have emerged as a crucial segment within the advanced wound dressing market due to their superior absorption capabilities and comfort for patients. These dressings are particularly effective in managing exuding wounds, as they provide a moist environment that enhances the healing process. They are often used for chronic wounds such as venous ulcers and diabetic foot ulcers. The material composition also allows for a high level of breathability, which is essential in preventing maceration. Furthermore, foam dressings can be easily cut and shaped to fit various wound sizes and locations, making them versatile for clinical and home care settings. Innovations in foam technology, including the incorporation of antimicrobial agents, are further propelling the demand for this product type, making it a dominant segment in the market.

Hydrocolloid Dressings:

Hydrocolloid dressings are gaining traction in the advanced wound dressing market due to their unique ability to create a moist wound environment that accelerates healing while also providing autolytic debridement. These dressings are particularly effective for low to moderate exuding wounds and are often utilized for pressure ulcers and post-operative wounds. The adhesive nature of hydrocolloids ensures secure placement, reducing the frequency of dressing changes. Their biocompatibility and ability to conform to the wound shape make them a preferred choice among healthcare providers. Furthermore, the development of hydrocolloid formulations that incorporate silver or other antimicrobial agents is enhancing their efficacy against infections, which is becoming increasingly important in wound management strategies.

Alginate Dressings:

Alginate dressings play a pivotal role in the management of highly exuding wounds due to their excellent absorbent properties derived from seaweed. These dressings transform into a gel-like substance upon contact with wound exudate, providing a moist environment that is conducive to healing while effectively controlling the amount of fluid loss. Alginate dressings are particularly beneficial for wounds such as venous ulcers, surgical wounds, and other chronic wounds where exudate management is critical. They also support the formation of granulation tissue, thereby facilitating the healing process. Additionally, alginate products that are infused with antimicrobial agents are gaining popularity as they not only manage exudate but also reduce the risk of infection, making them a key player in the advanced wound dressing market.

Film Dressings:

Film dressings are characterized by their thin, transparent, and flexible nature, making them ideal for superficial wounds and as secondary dressings over primary dressings. They provide a barrier to external contaminants while allowing for oxygen exchange, which is crucial for wound healing. These dressings are often used for minor surgical wounds, abrasions, and as a protective layer over intravenous sites. The waterproof quality of film dressings also makes them suitable for daily activities, including bathing. Furthermore, their transparency allows for easy monitoring of the wound without removal. The advancements in adhesive technologies have also led to improved wear times and lower rates of skin irritation, further enhancing the appeal of film dressings in clinical practice.

Hydrogel Dressings:

Hydrogel dressings are increasingly recognized for their ability to provide moisture to dry and necrotic wounds, which is vital for the healing process. Their formulation typically includes water and gel-forming agents, creating a soothing environment that minimizes pain and discomfort for the patient. Hydrogel dressings are particularly effective in managing superficial burns, abrasions, and dry wounds, as they promote autolytic debridement. The cooling effect of hydrogel dressings also contributes to pain relief, making them a preferred choice for patients experiencing discomfort. With their biocompatibility and ability to maintain a moist environment, hydrogel dressings are becoming an essential component of advanced wound care, with ongoing innovations aimed at enhancing their healing properties.

By Application

Chronic Wounds:

The chronic wounds segment is one of the most significant within the advanced wound dressing market, driven by the increasing prevalence of conditions such as diabetes and obesity, which lead to complications like diabetic ulcers and pressure sores. The management of chronic wounds requires specialized dressings that can cope with prolonged healing times and the presence of exudate. Advanced wound dressings in this segment are designed to facilitate faster healing by maintaining a moist environment, providing thermal insulation, and managing bacterial colonization effectively. As the population ages and the incidence of these chronic conditions rises, the demand for effective wound care solutions continues to grow, propelling advancements in dressing technologies tailored specifically for chronic wound management.

Acute Wounds:

Acute wounds, including surgical incisions, traumas, and abrasions, represent a dynamic segment of the advanced wound dressing market. The need for quick healing and infection prevention in these cases is imperative, leading to the increasing adoption of advanced dressings that offer superior moisture management and barrier protection. Dressings used for this application focus on minimizing pain, promoting healing, and reducing the risk of complications such as infections. The segment is characterized by a wide range of dressing types, including hydrocolloids and film dressings, which are specifically tailored to meet the varying needs of acute wound management. The rise in surgical procedures and trauma cases is expected to bolster demand for effective advanced wound dressings in this application category.

Surgical Wounds:

The surgical wounds application segment is poised for significant growth due to the rising number of surgical procedures performed globally. Advanced wound dressings are critical in this context as they not only protect the wound but also facilitate optimal healing while minimizing the risk of infection. The use of specialized dressings that incorporate antimicrobial properties is increasing in surgery settings as they serve to enhance patient outcomes and reduce hospital stay durations. Additionally, innovations in surgical wound care, including the development of dressings that can absorb excess exudate while maintaining a moist environment, are crucial for managing post-operative wounds effectively. As healthcare facilities continue to emphasize wound management protocols, the surgical wounds segment is expected to contribute significantly to overall market growth.

By Distribution Channel

Hospitals:

The hospital distribution channel represents a significant segment of the advanced wound dressing market, driven by the high volume of patients requiring wound care services. Hospitals often utilize advanced dressings as part of their standard protocols for managing surgical and chronic wounds due to their effectiveness in promoting faster healing and reducing infection rates. Availability of a wide array of dressing options within hospitals enables healthcare professionals to select the most appropriate wound management solutions tailored to individual patient needs. Additionally, hospitals are increasingly adopting evidence-based practices which, along with ongoing training for healthcare staff on the latest wound care technologies, are contributing to the growing demand for advanced dressings in this setting.

Clinics:

Clinics are an important distribution channel for advanced wound dressings, particularly for outpatient care settings where patients require ongoing wound management following surgical procedures or injury. The accessibility of advanced dressings in clinics allows healthcare providers to offer tailored wound care solutions that meet the specific needs of their patients. Moreover, with the rise of specialized wound care clinics, there is an increasing focus on advanced wound care products that facilitate effective healing and minimize the risk of complications. The ability to provide immediate care and appropriate wound dressing options in clinical settings is essential in ensuring optimal patient outcomes, making this distribution channel a key player in the market.

Home Care Settings:

The home care settings distribution channel is experiencing substantial growth as more patients prefer to manage their wound care in the comfort of their homes. The increasing aging population and the growing prevalence of chronic conditions necessitate effective home care solutions, leading to a higher demand for advanced wound dressings that are easy to use and provide effective healing outcomes. Advanced wound care products designed for home use often prioritize ease of application and removal, as well as minimizing discomfort. This shift towards home care is driven by a focus on reducing healthcare costs and improving patient satisfaction, making advanced wound dressings accessible to a broader audience.

By Ingredient Type

Collagen:

Collagen-based dressings are gaining traction in the advanced wound dressing market due to their biological properties that promote healing. Collagen is a key protein in the human body that plays an essential role in wound healing by facilitating cell migration and matrix formation. These dressings are particularly effective for chronic wounds, as they help to stimulate the body's natural healing processes. The application of collagen dressings not only enhances granulation tissue formation but also provides a moist environment conducive to healing. With a growing body of evidence supporting their efficacy, collagen-based dressings are increasingly being integrated into clinical wound care protocols.

Silicone:

Silicone dressings have become increasingly popular in the advanced wound dressing market due to their unique properties that offer flexibility and comfort for patients. These dressings are particularly suitable for sensitive skin and can be used for a variety of wound types, including surgical and chronic wounds. The gentle adhesion of silicone dressings reduces pain upon removal, making them an ideal choice for patients with fragile skin. Additionally, silicone dressings provide a moist healing environment, which is essential for wound healing and helps to prevent maceration. Overall, their versatility and patient-friendly properties are driving the demand for silicone in advanced wound care solutions.

Silver:

Silver-infused dressings have been widely adopted in the advanced wound dressing market due to their antimicrobial properties, which are essential in managing infected wounds. These dressings release silver ions that have been proven to effectively combat a broad spectrum of pathogens, thereby reducing the risk of wound infection. Silver dressings are particularly useful for chronic wounds and surgical wounds where the risk of infection is high. The combination of silver with various dressing technologies, such as foam and hydrocolloid, enhances their effectiveness while maintaining a moist environment conducive to healing. As awareness of infection control grows, the demand for silver-infused dressings is expected to rise significantly.

Honey:

Honey-based dressings are emerging as a natural alternative in the advanced wound dressing market due to their antibacterial and anti-inflammatory properties. Medical-grade honey has been shown to effectively promote wound healing by providing a moist environment and facilitating autolytic debridement. Moreover, honey’s osmosis effect helps in drawing out excess fluid from the wound, which aids in minimizing infection risks. The use of honey dressings is particularly beneficial for chronic wounds, as well as burns and surgical wounds, due to their soothing properties. The growing preference for natural and biocompatible wound care solutions is driving the demand for honey-based dressings, marking a significant trend in the market.

Growth Factors:

Growth factor-infused dressings have become a cutting-edge solution in the advanced wound dressing market, particularly for chronic and complex wounds. These dressings are designed to release bioactive substances that facilitate tissue repair and regeneration by promoting cell proliferation and differentiation. The application of growth factors, such as platelet-derived growth factor (PDGF) and epidermal growth factor (EGF), accelerates the healing process by stimulating the body’s natural response to injury. The increasing emphasis on personalized medicine and targeted therapies is driving research and development in growth factor technology, making these dressings increasingly popular among healthcare providers for managing challenging wounds effectively.

By Region

North America is expected to dominate the advanced wound dressing market with a valuation of approximately USD 4.5 billion by 2035, owing to the robust healthcare infrastructure, high prevalence of chronic diseases, and an increasing aging population. The U.S. particularly leads in the adoption of advanced wound care technologies, with significant investments in healthcare facilities and an emphasis on innovative wound management solutions. Furthermore, the presence of key manufacturers and the increasing number of specialized wound care clinics are anticipated to contribute to substantial market growth in the region. With a projected CAGR of 6.2%, North America remains a central hub for advancements in wound care technology, setting benchmarks for other regions.

Europe also holds a substantial share of the advanced wound dressing market, estimated at around USD 3.2 billion by 2035, primarily driven by the increasing healthcare expenditure and the high incidence of surgical procedures. The region is experiencing a growing demand for advanced wound dressings, especially in the U.K., Germany, and France, due to the rising awareness of advanced wound care products among healthcare providers. The European market is characterized by a strong focus on research and development, leading to innovations in dressing technologies tailored for chronic and acute wound management. Additionally, the presence of several prominent market players in the region is expected to further propel market growth as they expand their portfolios to include advanced wound care solutions.

Opportunities

The advanced wound dressing market presents numerous opportunities, particularly in developing economies where healthcare infrastructure is rapidly evolving. As these regions experience improvements in healthcare access, there is a growing demand for effective wound management products. The increasing prevalence of chronic diseases in these markets highlights the necessity for advanced wound care solutions that can significantly enhance healing outcomes. Furthermore, partnerships between local manufacturers and global companies can facilitate the introduction of innovative products tailored to regional needs, presenting lucrative growth opportunities. Investment in educational programs for healthcare professionals regarding the benefits of advanced wound care practices could also stimulate market expansion in these regions, driving the adoption of advanced wound dressings.

Another promising opportunity lies within the realm of technological advancements and innovation in the wound care industry. The integration of smart technologies, such as biosensors and telemedicine, can revolutionize wound management by providing real-time monitoring and tailored treatment plans. This convergence of technology and advanced wound care products can enhance patient engagement and adherence to treatment protocols while improving overall healing outcomes. Moreover, ongoing research focused on developing next-generation wound dressings that incorporate not only antimicrobial properties but also regenerative features is likely to open new avenues in the market. The potential for personalized wound care solutions through tailored dressings based on individual patient needs is a key opportunity that could redefine the landscape of advanced wound management.

Threats

Despite the promising growth trajectory, the advanced wound dressing market faces several threats that could impede its progress. One of the primary concerns is the increasing competition among manufacturers, leading to price wars that can compromise product quality and innovation. The saturation of low-cost alternatives in emerging markets poses a significant challenge to established players who rely on premium pricing for advanced wound care products. Additionally, the rapid pace of technological advancements requires companies to continuously invest in research and development to stay relevant in the market, which can strain financial resources. Furthermore, regulatory hurdles and compliance with stringent healthcare standards can delay the introduction of new products, affecting market competitiveness.

Another threat to the advanced wound dressing market is the growing trend towards alternative wound management practices, including natural and holistic approaches that may not rely on conventional advanced dressings. Patients are increasingly seeking out alternative therapies, which may impact the demand for traditional advanced wound care products. Moreover, economic fluctuations and disruptions, such as the recent pandemic, have underscored vulnerabilities in supply chains, leading to potential shortages of wound dressing materials. This not only affects availability but can also drive up costs, leading to increased pressure on healthcare providers and patients alike. Addressing these threats will require innovative strategies and a focus on enhancing product offerings to meet evolving patient needs.

Competitor Outlook

• 3M Company
• Smith & Nephew Plc
• Medtronic Plc
• Coloplast A/S
• ConvaTec Group Plc
• Johnson & Johnson
• Hollister Incorporated
• BSN Medical
• Derma Sciences, Inc.
• Cardinal Health, Inc.
• Integra LifeSciences Holdings Corporation
• Moore Medical LLC
• Fujifilm Holdings Corporation
• Medline Industries, Inc.
• Wound Care Technologies, Inc.

The competitive landscape of the advanced wound dressing market is characterized by a mixture of established multinational companies and emerging players, all vying for market share through product innovation and strategic collaborations. Major players like 3M Company and Smith & Nephew Plc are leading the charge in introducing advanced technologies and materials, setting industry standards for performance and safety. Their extensive research and development efforts have resulted in a diverse portfolio of products catering to various wound types and patient needs, reinforcing their dominance in the market. Additionally, collaborations with healthcare providers and researchers allow these companies to stay at the forefront of wound care advancements, tailoring their offerings to meet the specific challenges faced in clinical settings.

In addition to established players, several smaller companies and startups are entering the market with innovative solutions and niche products. Companies like Derma Sciences, Inc. and Wound Care Technologies, Inc. are focusing on unique materials and advanced technologies, such as growth factor-infused dressings that cater to specialized wound management needs. These emerging players often capitalize on specific market gaps, offering customized solutions that appeal to healthcare providers looking for effective treatment options. The presence of a variety of competitors, ranging from large corporations to niche innovators, fosters a dynamic environment that encourages ongoing advancements and enhancements in wound care technologies.

Furthermore, strategic mergers and acquisitions are becoming more prevalent as companies seek to expand their market presence and diversify their product offerings. For instance, Medtronic Plc’s acquisition of Covidien has strengthened its position in the advanced wound dressing market by integrating complementary technologies and enhancing its reach in the global market. Such strategic moves not only bolster product portfolios but also allow companies to leverage each other's strengths in research and development, thus accelerating innovation. As competition intensifies, companies will need to focus on enhancing their value propositions by investing in advanced technologies, superior customer service, and comprehensive wound care solutions that address the multifaceted needs of patients and healthcare providers alike.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 BSN Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Coloplast A/S
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic Plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Moore Medical LLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 ConvaTec Group Plc
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Smith & Nephew Plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Derma Sciences, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hollister Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fujifilm Holdings Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Wound Care Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Integra LifeSciences Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Advanced Wound Dressing Market, By Application
    • 6.1.1 Chronic Wounds
    • 6.1.2 Acute Wounds
    • 6.1.3 Surgical Wounds
  • 6.2 Advanced Wound Dressing Market, By Product Type
    • 6.2.1 Foam Dressings
    • 6.2.2 Hydrocolloid Dressings
    • 6.2.3 Alginate Dressings
    • 6.2.4 Film Dressings
    • 6.2.5 Hydrogel Dressings
  • 6.3 Advanced Wound Dressing Market, By Ingredient Type
    • 6.3.1 Collagen
    • 6.3.2 Silicone
    • 6.3.3 Silver
    • 6.3.4 Honey
    • 6.3.5 Growth Factors
  • 6.4 Advanced Wound Dressing Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Home Care Settings

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Advanced Wound Dressing Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Advanced Wound Dressing market is categorized based on

By Product Type

• Foam Dressings
• Hydrocolloid Dressings
• Alginate Dressings
• Film Dressings
• Hydrogel Dressings

By Application

• Chronic Wounds
• Acute Wounds
• Surgical Wounds

By Distribution Channel

• Hospitals
• Clinics
• Home Care Settings

By Ingredient Type

• Collagen
• Silicone
• Silver
• Honey
• Growth Factors

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• 3M Company
• Smith & Nephew Plc
• Medtronic Plc
• Coloplast A/S
• ConvaTec Group Plc
• Johnson & Johnson
• Hollister Incorporated
• BSN Medical
• Derma Sciences, Inc.
• Cardinal Health, Inc.
• Integra LifeSciences Holdings Corporation
• Moore Medical LLC
• Fujifilm Holdings Corporation
• Medline Industries, Inc.
• Wound Care Technologies, Inc.